Ramón Limón

Generalitat Valenciana — Spain

Medicine · Health Sciences

6h-index116citations11works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(10), COVID-19 Clinical Research Studies(7), SARS-CoV-2 detection and testing(4), COVID-19 and Mental Health(2), Vaccine Coverage and Hesitancy(2)

Publications11 total

Seroprevalence of antibodies against SARS-CoV-2 in the Valencian Community (Spain) as of October 2022
Gaceta Sanitaria·2023· 1 citedOpen Access
Neutralizing antibodies against Omicron BA.4/5 after COVID-19 vaccination in SARS-CoV-2 experienced versus naïve individuals in the general population
Journal of Infection·2023· 3 citedOpen Access
Cumulative incidence of SARS‐CoV‐2 infection in the general population of the Valencian Community (Spain) after the surge of the Omicron BA.1 variant
Journal of Medical Virology·2022· 14 citedOpen Access
Side effects during the week after first dose vaccination with four Covid-19 vaccines. Results of the ProVaVac Survey Study with 13,837 people in Spain
Vaccine·2022· 13 citedOpen Access
Cumulative incidence of SARS-CoV-2 infection in the general population of the Valencian Community (Spain) after the surge of the Omicron BA.1 variant
2022· 3 citedOpen Access
SARS‐CoV‐2 Omicron BA.1 variant breakthrough infections in nursing home residents after an homologous third dose of the Comirnaty® COVID‐19 vaccine: Looking for correlates of protection
Journal of Medical Virology·2022· 17 citedOpen Access
SARS‐CoV‐2 Delta‐variant breakthrough infections in nursing home residents at midterm after Comirnaty® COVID‐19 vaccination
Journal of Medical Virology·2022· 7 citedOpen Access
Severe Acute Respiratory Syndrome Coronavirus 2 Adaptive Immunity in Nursing Home Residents Following a Third Dose of the Comirnaty Coronavirus Disease 2019 Vaccine
Clinical Infectious Diseases·2022· 26 citedOpen Access
SARS-CoV-2 adaptive immunity in nursing home residents up to eight months after two doses of the Comirnaty® COVID-19 vaccine
Journal of Infection·2022· 3 citedOpen Access
Immunological response against SARS-CoV-2 following full-dose administration of Comirnaty® COVID-19 vaccine in nursing home residents
Clinical Microbiology and Infection·2021· 24 citedOpen Access
Use of RB51 Vaccine for Small Ruminants Brucellosis Prevention, in Veracruz, Mexico
International Journal of Dairy Science·2009· 5 citedOpen Access

Frequent Co-authors

Salvador Peiró(12), Javier S. Burgos(10), Hermelinda Vanaclocha(10), José Sánchez–Payá(10), David Navarro(10), Javier Díez‐Domingo(9), Estela Giménez(8), Eliseo Albert(8), Iñaki Comas(8), Fernando Gónzález‐Candelas(8), João Zulaica(5), Ignacio Torres(5), Dolores Salas(5), María Jesús Alcaráz(5), Ron Geller(5), Luciana Rusu(4), Beatriz Álvarez‐Rodríguez(3), Jorge Camacho(3), R. Meneu de Guillerna(2), D. J. Burks(2)